Evidence map›Paper›PMID 42827744›Full record

ReviewFrontiers in immunology2026

Non-immune regulation of tertiary lymphoid structures in cancer.

Owen K Challen, Evelyn Fitzsimons, Wyatt W Anderson, Daniella Liao, Willie Wu, Vanessa G P Souza, Katya H Bénard, Julia R Naso, Spencer D Martin, Wan L Lam and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Owen K ChallenBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Evelyn FitzsimonsBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Wyatt W AndersonBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Daniella LiaoBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Willie WuBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Vanessa G P SouzaBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Katya H BénardBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Julia R NasoPathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Spencer D MartinDepartment of Pathology, Dalhousie University, Halifax, NS, Canada.
Wan L LamBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.
Katey S S EnfieldBasic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tertiary lymphoid structures (TLS) are ectopic immune aggregates that form in response to chronic inflammation, and their presence across many solid tumors has been associated with improved survival and enhanced responses to immunotherapy. Although current models primarily characterize TLS through the lens of immune aggregation and organization, their formation also depends on reciprocal interactions with the non-immune tumor microenvironment. Fibroblasts, vasculature, extracellular matrix architecture, and tumor metabolism collectively influence TLS development, suggesting that these structures function as emergent tissue ecosystems rather than as immune aggregates alone. In this review, we summarize current evidence on how cancer-associated fibroblasts and the tumor vasculature regulate immune cell recruitment and organization through context-dependent expression of chemokines, adhesion molecules, structural barriers, and vascular niches, before considering how extracellular matrix remodeling and tumor metabolism further shape TLS neogenesis and maturation. Across these processes, non-immune components exhibit dual functions, promoting TLS formation in some contexts while reinforcing immune exclusion and antagonizing TLS in others. We further discuss current spatial technologies that enable in-depth quantification of TLS structure and maturity and clarify the contribution of non-immune components to TLS biology. Due to this increased appreciation of their biological relevance, we discuss the promise of non-immune components as rational targets for combination strategies to enhance TLS function and immunotherapy efficacy.

Indexed as

NeoplasmsTertiary Lymphoid StructuresTumor MicroenvironmentAnimalsCancer-Associated FibroblastsExtracellular MatrixHumanscancer-associated fibroblastscancer metabolismhigh endothelial venulesimmunotherapy responsespatial biologytertiary lymphoid structurestumor microenvironment

Identifiers

PMID42827744
PMCPMC13631734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.